National Health Investors Inc. (NYSE:NHI)’s share price hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $78.23 and last traded at $78.06, with a volume of 101,958 shares. The stock had previously closed at $76.68.

NHI has been the topic of a number of research reports. BMO Capital Markets boosted their target price on shares of National Health Investors from $65.00 to $69.00 and gave the stock an “outperform” rating in a research report on Wednesday, March 30th. Cantor Fitzgerald started coverage on shares of National Health Investors in a research note on Thursday, June 23rd. They set a “hold” rating and a $70.00 price target on the stock. JMP Securities reiterated a “hold” rating on shares of National Health Investors in a research note on Thursday, March 31st. Finally, Zacks Investment Research downgraded shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Thursday, May 12th. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $70.17.

The company’s 50 day moving average is $74.46 and its 200 day moving average is $67.26. The stock has a market cap of $3.00 billion and a P/E ratio of 19.49.

National Health Investors (NYSE:NHI) last released its quarterly earnings data on Friday, May 6th. The real estate investment trust reported $1.16 earnings per share for the quarter, missing the consensus estimate of $1.17 by $0.01. During the same quarter in the previous year, the business earned $1.13 earnings per share. The company earned $59.02 million during the quarter, compared to analyst estimates of $57.81 million. The firm’s quarterly revenue was up 5.0% compared to the same quarter last year. Analysts expect that National Health Investors Inc. will post $4.87 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 10th. Investors of record on Thursday, June 30th will be paid a $0.90 dividend. This represents a $3.60 annualized dividend and a yield of 4.61%. The ex-dividend date of this dividend is Tuesday, June 28th.

In other news, Director Robert A. Mccabe, Jr. sold 1,250 shares of National Health Investors stock in a transaction dated Monday, June 13th. The stock was sold at an average price of $71.61, for a total transaction of $89,512.50. Following the sale, the director now directly owns 9,736 shares of the company’s stock, valued at $697,194.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Kristin Sallee Gaines sold 8,652 shares of National Health Investors stock in a transaction dated Wednesday, June 29th. The shares were sold at an average price of $73.98, for a total value of $640,074.96. Following the sale, the insider now directly owns 53,089 shares in the company, valued at $3,927,524.22. The disclosure for this sale can be found here.

Several hedge funds have recently made changes to their positions in the stock. New York State Common Retirement Fund raised its stake in shares of National Health Investors by 2.9% in the fourth quarter. New York State Common Retirement Fund now owns 35,300 shares of the real estate investment trust’s stock worth $2,149,000 after buying an additional 1,000 shares during the last quarter. Advantus Capital Management Inc raised its stake in shares of National Health Investors by 3.7% in the fourth quarter. Advantus Capital Management Inc now owns 50,606 shares of the real estate investment trust’s stock worth $3,080,000 after buying an additional 1,800 shares during the last quarter. Rhumbline Advisers raised its stake in shares of National Health Investors by 2.2% in the fourth quarter. Rhumbline Advisers now owns 62,343 shares of the real estate investment trust’s stock worth $3,795,000 after buying an additional 1,320 shares during the last quarter. Schroder Investment Management Group purchased a new stake in shares of National Health Investors during the fourth quarter worth approximately $4,973,000. Finally, Westfield Capital Management Co. LP raised its stake in shares of National Health Investors by 81.4% in the fourth quarter. Westfield Capital Management Co. LP now owns 436,425 shares of the real estate investment trust’s stock worth $26,565,000 after buying an additional 195,807 shares during the last quarter.

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.